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Abstract
Thymic epithelial cell differentiation, growth and function depend on the expression of the 
transcription factor Foxn1, however its target genes have never been physically identified. Using 
novel static and inducible genetic model systems and chromatin studies, we provide now a genome 
wide map of direct Foxn1 target genes for postnatal thymic epithelia and define the Foxn1 binding 
motif. We detail the function of Foxn1 in these cells and demonstrate that in addition to the 
transcriptional control of genes involved in the attraction and lineage commitment of T cell 
precursors, Foxn1 regulates the expression of genes involved in antigen processing and thymocyte 
selection. Thus, critical events in thymic lympho-stromal cross-talk and T cell selection are 
indispensably choreographed by Foxn1.
The thymic microenvironment is unique in its ability to promote the development and 
selection of naïve T cells with a repertoire purged of vital “self” specificities but prepared to 
react to injurious “non-self”. Thymic epithelial cells (TEC), which can be categorized into 
separate cortical (cTEC) and medullary (mTEC) lineages1,2, are essential for this 
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competence. cTEC attract blood-borne precursor cells, commit them to a T cell fate and 
foster their differentiation to express an αβT cell antigen receptor (TCR). Reactivity to 
major histocompatibility complex (MHC)-peptide complexes presented by TEC authorizes 
the generation of a bespoke TCR repertoire. Because TCR are initially generated pseudo-
randomly, their specificity is scrutinized during thymocyte development to establish a 
selected repertoire tailored for an individual whereby cTEC positively select thymocytes that 
express a TCR of sufficient affinity for self-antigens3. Subsequently, both cTEC and mTEC 
deplete thymocytes with significant reactivity to self-antigens, a process known as negative 
selection4.
TEC differentiation and growth are dependent on transcription factor Foxn1 which is present 
in the thymus exclusively in TEC but not required there for the cells’ initial fate 
specification5,6,7. Foxn1 is continuously expressed in the thymus and may therefore be 
required for the maintenance of cortical and medullary TEC, both in the embryo and in 
postnatal mice8–10. This finding suggests that Foxn1 constantly controls diverse aspects of 
TEC biology, ranging from steps essential in early epithelial cell differentiation to the 
transcriptional control of genes important for thymus function and maintenance. Though 
several genes have been implicated to be transcriptionally controlled by Foxn1, none have 
physically been identified as direct targets. Using different static and inducible genetic 
mouse model systems, we now demonstrate in a genome wide manner the direct target genes 
of Foxn1. Among these are genes that contribute to antigen processing and presentation 
including threonine peptidases, components of the proteasome complex, protein transporters 
and CD83.
Results
A Foxn1 transgenic rescue of the nude thymus phenotype
The direct identification of Foxn1 target genes in TEC using chromatin immunoprecipitation 
sequencing (ChIP-seq) is impeded by a lack of suitable anti-Foxn1 antibodies. We therefore 
generated nude (Foxn1nu/nu) mice transgenic for a BAC11 that encodes a Foxn1 protein 
tagged with a Flag-octapeptide which is expressed under the normal control of Foxn1 
regulatory elements and permits immunoprecipitation (Supplementary Fig. 1a,b). 
Homozygous for the BAC, these mice (designated Foxn1wt*/wt*) had a regular coat and a 
gross anatomically normal thymus with an ordered stromal architecture and usual Foxn1 
protein expression. Total thymus and TEC cellularity were mildly reduced in mice 4 weeks 
or older when compared to age-matched wild type controls (Fig. 1a and Supplementary Fig. 
1c,f). Hence, the Foxn1-Flag protein in TEC of Foxn1wt*/wt* mice almost completely 
rescued the nude phenotype. In contrast to Foxn1wt*/wt* mice, nude mice heterozygous for 
the BAC allele (designated Foxn1wt*/-) had a significantly smaller thymus marked by 
reduced Foxn1 protein expression, fewer mTEC, multiple large cysts and a severely 
disorganized cortex-medulla segregation with medullary islands located adjacent to the 
organ’s capsule (Fig. 1a-e and Supplementary Fig. 1c,f). Furthermore, Foxn1wt*/- mice had 
fewer mature (MHChiCD80+CD86+) mTEC and their MHCII cell surface expression was 
reduced in comparison to wild type and Foxn1wt*/wt* mice (Fig. 1f-h). These results 
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therefore established the recombinant BAC as hypomorphic Foxn1 allele with expression of 
Foxn1-Flag from a single allele only partially rescuing the nude thymus phenotype.
Foxn1 acts at multiple stages of thymocyte differentiation and selection
We next evaluated the thymopoiesis of 4-6 week old Foxn1wt*/wt*, Foxn1wt*/- and wild type 
mice. The progression of early thymic precursors (ETP, which are Lin-CD4-CD8-CD44+c-
kit+ thymocytes, whereby lineage negativity, Lin-, refers to the absence of TCRβ, CD4, 
CD8, CD19, CD11c, CD11b, F4/80, TCRγδ, NK1.1, and TER119 expression) to 
CD4+CD8+ (double positive, DP) thymocytes was comparable for Foxn1wt*/wt* and wild 
type mice (Fig. 2a-c), indicating that homozygous BAC transgene rescued the early 
thymopoietic competence of Foxn1nu/nu TEC. In contrast, the frequency of ETP, a 
population that seeds the thymus in response to chemokines CCL19, CCL21 and CCL25 
expressed by TEC12, was 32-fold reduced in Foxn1wt*/- mice (Fig. 2a) whilst B cells were 
30-fold more frequent in Foxn1wt*/- mice relative to wild type animals (Supplementary Fig. 
2a). The frequency of the subsequent stages of Lin- thymocytes increased in Foxn1wt*/- mice 
relative to ETP but did not reach the values observed in wild type animals (Fig. 2b).
The frequency of mature CD4+ single-positive (CD4SP) and CD8+ single-positive (CD8SP) 
thymocytes was mildly reduced in Foxn1wt*/wt* and strongly diminished in Foxn1wt*/- mice 
when compared to wild type animals (Fig. 2c). These changes in Foxn1wt*/wt* and 
Foxn1wt*/- mice correlated with a reduced positive selection as measured by the upregulation 
of CD69 expression on thymocytes with an intermediate expression of the TCR despite an 
increased frequency of cTEC relative to that observed in wild type mice (Fig. 1e, Fig. 2d and 
Supplementary Fig. 2b). Because a decrease in CD4SP and CD8SP thymocytes could also 
be the consequence of increased clonal deletion, we next determined among cortical TCRhi 
DP thymocytes the frequency of negatively selected thymocytes marked by co-expression of 
PD1 and Helios in the absence Foxp3 and CCR7.13,14 Their frequency was diminished in 
both Foxn1wt*/wt* and Foxn1wt*/- mice in comparison to wild type animals (Fig. 2e).
We next investigated the post-selection maturation of medullary thymocytes. The up-
regulation of CCR7 on CD4SP thymocytes was reduced in Foxn1wt*/- mice (Fig. 2f) 
whereas the expression of Helios, a marker identifying cells undergoing Bim-mediated 
negative selection14, was at initial stages diminished but increased at later stages during 
maturation in Foxn1wt*/- mice relative to wild type mice (Fig. 2f), revealing increased 
negative selection of these cells. Medullary CD8SP thymocytes demonstrated in Foxn1wt*/- 
mice a decreased down-regulation of CD24, thus also revealing a partial block in maturation 
(Fig. 2g). Moreover, the differentiation of immature and mature regulatory T cells (Treg 
cells) was also diminished in Foxn1wt*/wt* and Foxn1wt*/- mice when compared to wild type 
animals (Fig. 2h and Supplementary Fig. 2c). Hence, an incomplete complementation of 
Foxn1 altered T cell development marked by a lower frequency of ETP, reduced positive 
selection, partial maturational blocks and a variance in negative thymocyte selection that 
resulted in fewer mature, post-selection thymocytes.
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Identification of Foxn1 binding sites and motifs
ChIP-seq analyses employing a Flag-tag specific antibody (Supplementary Fig. 3a) and TEC 
nuclear extracts from Foxn1wt*/wt* mice identified 9,012 peaks at an irreproducible 
discovery rate (IDR) of < 0.05. A third of these peaks were located immediately 5’ and 
within 5kb upstream of transcriptional start sites (TSS) (Fig. 3a,b). Overlap of these peaks 
with H3K4me3 marks was enriched approximately 23-fold (Supplementary Fig. 3b) and 75-
fold enhanced within open chromatin regions, as measured by ATAC-seq in cTEC (Fig. 3b). 
Approximately two-thirds (67.3%) of Foxn1 binding sites intersected ATAC-seq peaks and 
this value increased to 92.8% when considering only binding sites within regions 5kb 
upstream and 100 bases downstream of the transcriptional start sites (TSS) of genes. In 
contrast, Foxn1 showed a 0.53-fold reduction (p<0.0001) in binding near the TSS of genes 
encoding tissue restricted antigens relative to all others15.
Using a non-supervised method on all Foxn1 ChIP-seq peaks with an IDR<0.05, we 
identified, based on our results, a consensus Foxn1 binding motif of 5 nucleotides (GA-a/c-
GC) (Supplementary Fig. 3c,d). Focusing our analysis on peaks within 5kb upstream and 
100 bases downstream of the TSS refined the prediction of the Foxn1 binding motif to 
GACGC (Fig. 3c). This motif was associated with a higher binding affinity across all peaks, 
even after adjustment for GC content (GACGC: β = 6.1, p<0.0001; GAAGC: β = -0.8, p = 
0.44) and was strongly enriched (3.2-fold) around the summit of Foxn1 ChIP-seq peaks 
when compared to surrounding sequences (Fig. 3d). This Foxn1 core binding sequence is 
identical to a previously suggested motif found by in vitro studies16, further indicating the 
validity of our ChIP-seq analysis using primary TEC. Taken together, these results identified 
the Foxn1 core binding motif within regions of open chromatin in TEC and near the TSS.
Identification of Foxn1 target genes
Because transcription factor binding does not necessarily result in the transcriptional 
regulation of nearby genes, we analyzed the gene expression profiles of cTEC and mTEC 
isolated by FACS from 1 week old Foxn1wt*/wt* and Foxn1wt*/- mice, respectively 
(Supplementary Fig. 4a,b). Large numbers (8378 and 11690, respectively) of genes were 
differentially expressed in cTEC and mTEC of Foxn1wt*/- relative to Foxn1wt*/wt* mice 
(Supplementary Table 1) with the TEC transcriptional profiles of Foxn1wt*/wt* mice highly 
correlating with previously published data of wild type TEC15 (mean ± SD Spearman’s r - 
cTEC: 0.94 ± 0.00; mTEC: 0.92 ± 0.00).
To address the issue which of the TEC transcriptomic differences observed in Foxn1wt*/- 
mice are the consequence of a change in direct Foxn1-mediated gene regulation, we 
generated triple mutant mice (Psmb11-rtTA∷tetO-Cre∷Foxn17,8loxP/loxP), designated 
iFoxn1Δ7,8, in which exons 7 and 8 of the Foxn1 locus can be deleted in a doxycyclin (Dox)-
induced, cTEC-restricted fashion (Supplementary Fig. 5a-c). The thymi of these mice 
displayed in the absence of Dox treatment a regular architecture, epithelial composition and 
lymphopoietic function (Supplementary Fig. 6 and data not shown). Three days after Dox 
exposure, the thymus of these mice had largely lost Foxn1 expression (Supplementary Fig. 
6a) and displayed a decreased cellularity despite normal intrathymic T cell development, as 
assessed by CD4 and CD8 expression (Supplementary Fig. 6b,c). However, there was a 
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severe decrease in CD44+CD25+CD4-CD8-Lin- and CD44-CD25+CD4-CD8-Lin- 
thymocytes when comparing 3-day Dox-treated with untreated iFoxn1Δ7,8 mice (Fig. 4a). 
These results therefore demonstrated that continuous and steady state Foxn1 expression in 
postnatal cTECs is required for normal T cell development.
Transcriptome analysis of cTEC from 1 week old iFoxn1Δ7,8 mice isolated 3 days after Dox 
treatment identified 2506 differentially regulated genes compared to cTEC isolated from 
Dox treated iFoxn1Δ7,8 mice deficient for the TetO-Cre transgene and thus unresponsive to 
Dox (FDR<0.05) (Supplementary Table 1, Supplementary Fig. 4c). Many of the down-
regulated genes (566) most likely represented direct targets because their Foxn1 binding 
sites were placed within 5kb upstream and 100 bases downstream of their TSS and their 
transcripts decreased coincidental with a loss of full length Foxn1 transcripts, as 
demonstrated for several previously suspected Foxn1 target genes essential for early 
thymocyte development, including Ccl2512, Cxcl1217 and Dll418 (Fig. 4b). Samples from 
Foxn1wt*/wt* and Foxn1wt*/- mice segregated in principal component analysis first by cell 
type and then by genotype (Supplementary Fig. 7a) and samples from iFoxn1Δ7,8 mice 
separated in this analysis according to the presence or absence of the TetO-Cre transgene 
(Supplementary Fig. 7b). These observations therefore supported the validity of the mouse 
model to probe Foxn1 biology.
We next integrated the Foxn1 ChIP-seq data with TEC RNA-seq data from Foxn1wt*/wt*, 
Foxn1wt*/- and iFoxn1Δ7,8 mice. This enabled us to identify a set of high confidence genes 
both directly bound and transcriptionally regulated by Foxn1. 5,415 genes were identified by 
ChIP-seq that had Foxn1 peaks within 5kb upstream or 100 bases downstream of the TSS 
(Fig. 4c). Of these, 1749 genes contained at least one Foxn1 binding peak and were up-
regulated in TEC of Foxn1wt*/wt* relative to Foxn1wt*/- mice (Fig. 4c). Finally, 450 of the 
1148 genes bound by Foxn1 and up-regulated in cTEC of Foxn1wt*/wt* relative to Foxn1wt*/- 
mice were also up-regulated in iFoxn1Δ7,8 mice that lacked the TetO-Cre transgene in 
comparison to iFoxn1Δ7,8 mice able to delete Foxn1 in response to Dox treatment (Fig. 4c, 
Table 1 and Supplementary Table 2). Using the binding and expression target analysis 
(BETA) software package on our ChIP-seq and cTEC transcriptomic data indicated that 
Foxn1 functioned predominantly as a transcriptional activator (p < 10-7)19 because Foxn1 
ChIP-seq peaks were 1.92-fold more likely (p<0.01) to mark genes whose expression was 
decreased in cTEC of iFoxn1Δ7,8 mice in which Foxn1 had been deleted (Fig. 4d; 
Supplementary Fig. 8).
We next identified Foxn1 ChIP-seq peaks of cTEC genes that were placed near TSS and 
intersected an ATAC-seq peak, and compared those to ChIP-seq peaks that did not have such 
an association. There was no significant difference in the log2 fold change of gene 
expression between cTEC from iFoxn1Δ7,8 mice or iFoxn1Δ7,8 mice that lacked the TetO-
Cre transgene (p=0.14). However, the presence of an ATAC-seq peak in cTEC was 
predictive in iFoxn1Δ7,8 mice of the magnitude of expression for genes with a nearby Foxn1 
ChIP-seq peak (ATAC-seq peak vs. no ATAC-seq peak: 2.4-fold, p<0.0001).
The high confidence Foxn1 gene targets we had identified demonstrated a higher median 
chromatin accessibility in cTEC when compared to all other genes (p<0.0001; Fig. 4e). 
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mRNA expression from high confidence genes showed a significant linear relationship with 
the relative proportion of full-length, wild type Foxn1 transcripts in iFoxn1Δ7,8 mice 
(Supplementary Fig. 9). Most of these high confidence Foxn1 targets were highly expressed 
in cTEC of Foxn1wt*/wt* mice (FPKM > 10: 360 genes), although many of them were also 
expressed in mTEC of Foxn1wt*/wt* mice (FPKM > 1: 428 genes; Fig. 4f), suggesting that 
our approach identified genes of importance to general TEC biology. To check that these 
high confidence Foxn1 targets were not driven by contamination with other thymic stromal 
cells, we screened the Foxn1 target genes identified in TEC against a list of potential 
contaminants derived from a previous microarray study of cell types resident in the thymus.
22,23 None of the high confidence Foxn1 targets were identified as being derived from 
contaminating cell types.
We next assessed whether the comparison between cTEC from Foxn1wt*/wt* and Foxn1wt*/- 
mice captured similar underlying transcriptomic changes as was observed for cTEC from 
Dox-treated iFoxn1Δ7,8 mice when compared to cTEC from Dox-treated iFoxn1Δ7,8 mice 
lacking the TetO-Cre transgene. The direction of overall expression changes in the two 
models showed a modest agreement (Spearman’s r = 0.46, p<0.0001). When restricting this 
analysis only to genes that were significant (FDR < 0.05) in both models, the agreement was 
more marked (Spearman’s r = 0.81, p<0.0001; Supplementary Fig. 10), suggesting that the 
models were capturing aspects of the same underlying biological processes and that the 
ability to identify and validate genes potentially regulated by Foxn1 was enhanced by the 
intersection of these two datasets. We have therefore employed ChIP-seq and RNA-seq 
datasets to identify a core set of 450 high confidence Foxn1 target genes.
Foxn1 targets are associated with antigen processing and presentation
We used gene ontology analysis20 to identify the biological categories to which high 
confidence Foxn1 target genes contribute. A significant enrichment was observed for 
categories involving threonine peptidases including Tasp1, the_components of the 
proteasome complex, such as Psmb9, Psmb10, Psmb4 and Psma4 (16.7-fold and 7.29-fold 
respectively; p<0.0001; Fig. 4g and Supplementary Table 3) and protein transporters 
including Tap2 required for antigen presentation by MHCI. In addition, we identified the 
expression of Prss16, which encodes a thymus specific serine protease expressed in cTEC 
and required for CD4 lineage selection and high MHCII expression21, to be regulated by 
Foxn1 (Table 1). Thus, Foxn1 controls multiple mechanisms critical for self-antigen 
processing and presentation.
Given this significant association of Foxn1 expression with pathways involved in antigen 
presentation, we next tested whether there was a differential expression of Aire-regulated 
genes between mTEC of Foxn1wt*/wt* and Foxn1wt*/- mice. As a group, Aire-regulated 
genes tended to be more highly expressed in mTEC of Foxn1wt*/wt* than Foxn1wt*/- mice 
when compared to either Aire-independent tissue restricted antigens or all other protein-
coding genes (median fold change: Aire-induced tissue restricted antigens 2.93-fold, other 
Aire-induced genes 2.61-fold, Aire-independent tissue restricted antigens 1.14-fold, and 
other protein-coding genes 1.00-fold; p<0.05 for all pair-wise comparisons). As Aire 
expression was comparable in mTEC of Foxn1wt*/wt* and Foxn1wt*/- mice (1.10-fold, 
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p=0.23), these findings suggest that Foxn1 expression facilitates promiscuous gene 
expression in a fashion that is independent but complementary to Aire.
We then used existing TEC transcriptomic datasets to place our high-confidence Foxn1 
targets in the context of a cTEC-specific co-expression network constructed using 
microarray data generated at multiple developmental time points22,23. We used weighted 
gene co-expression network analysis to identify gene modules containing more Foxn1 
targets than expected by chance (Supplementary Fig. 11; Supplementary Table 4). Dll4, 
Ccl25 and several other putative high confidence Foxn1 targets were significantly enriched 
within a gene module associated with the regulation of T cell activity (Supplementary Table 
4). The high confidence Foxn1 targets formed in cTEC a biological coexpression network 
(p<0.002) where Foxn1 represented a highly connected central hub (Supplementary Fig. 
12a). Hence, Foxn1 target genes formed an interconnected co-expression hub associated 
with antigen processing and presentation.
Identification of Foxn1 co-factors
To identify DNA binding factors that could cooperate with Foxn1 in controlling gene 
expression, we next searched for known transcription factor recognition motifs within and 
adjacent to Foxn1 ChIP-seq peaks. This analysis identified several motifs that were 
significantly and centrally overrepresented when compared to a background of mixed 
promoter and enhancer regions (Supplementary Fig. 12b,c)24. Among these were binding 
sites for the transcription factors CREB1 and TP63, which are known to regulate 
proliferation and TEC aging, respectively25,26. Foxn1 binding in TEC was 11.7-fold 
enriched near TP63 binding sites previously recognized in Foxn1 expressing keratinocytes 
(p < 0.0001), supporting a Foxn1-TP63 axis regulating TEC homeostasis26,27. We thus 
identified a number of potential Foxn1 co-factors, of which TP63 is a particularly 
biologically plausible candidate.
Psmb11 and Cd83 are direct Foxn1 targets
Psmb11, encoding the proteasome component β5t, and Cd83 were identified as two high 
confidence Foxn1 target genes (Table 1). As early as 24 hours post-Dox treatment, 
transcripts for both genes were significantly reduced in cTEC from iFoxn1Δ7,8 mice when 
compared to untreated iFoxn1Δ7,8 mice (Fig. 5a), suggesting the genes’ direct transcriptional 
control by Foxn1. Psmb11 is expressed almost exclusively in cTECs and is pivotal for 
positive selection of CD8+ T cells28,29. CD83 is a surface marker expressed in cTEC that is 
required for the development of CD4SP cells.30 A single Foxn1 binding peak was identified 
upstream of Psmb11’s TSS that contained two copies of the Foxn1 binding motif GACGC 
and two copies of the predicted alternative motif GAAGC. The Cd83 promoter contained a 
proximal GACGC and three distal GAAGC motifs (Fig. 5a). The functional significance of 
these binding sites was investigated in HEK293 cells co-transfected with a Foxn1 expression 
plasmid and a luciferase construct containing the Psmb11 and the Cd83 promoter, 
respectively, each without or with disrupted consensus motifs. Mutations of the proximal 
and, to a lesser degree, distal GACGC motifs of the Psmb11 promoter significantly 
decreased luciferase activity, whereas changes to both ablated transcription altogether (Fig. 
5b). Deletion of the single GACGC motif in the promoter of Cd83 decreased the 
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transcriptional activity by half and removal of the promoter sequence containing the distal 
two GAAGC motifs reduced transcription by two-thirds (Fig. 5c). Mutating the proximal 
GAAGC in the truncated promoter, in contrast to removal of GACGC, had no effect on the 
transcriptional activity (Fig. 5c). Thus, the provision of Foxn1 in heterologous HEK293 cells 
is sufficient to activate the minimal Psmb11 and Cd83 promoters, each containing intact 
GACGC Foxn1 binding motifs.
In comparison to wild type animals, Foxn1wt*/- mice had 4-fold fewer CD8SP thymocytes 
(Fig. 5d), which correlated with a partial block in thymocyte selection, as measured by 
CD69 and TCR surface expression (Fig. 5e). These changes closely but not completely 
mirrored those observed in Psmb11-deficient mice (Fig. 5d,e). We therefore investigated the 
negative selection of cortical (i.e. CCR7-) DP thymocytes as marked by their simultaneous 
expression of PD-1 and Helios.14 In contrast to wild type but similar to Psmb11-/- mice, the 
frequency of PD1+Helios+ DP thymoyctes was reduced by half in Foxn1wt*/- animals (Fig. 
5f), suggesting a compromised negative thymocyte selection in the absence of normal Foxn1 
complementation and thus regular Psmb11 expression. Identical to Psmb11-/- mice, 
Foxn1wt*/- animals, in contrast to wild type mice, had also 4-fold fewer TCRhiCD5int DP 
thymocytes (Fig. 5g), a population representing CD8 lineage committed DP thymocytes.31 
CD8SP thymocytes of both Foxn1wt*/- and Psmb11-/- mice exhibited a reduced 
downregulation of CCR7 and CD24 expression when compared to wild type animals (Fig. 
5h), revealing a block in thymocyte maturation at the post-selection stage. A loss in regular 
Foxn1 expression in Foxn1wt*/- mice resulted in decreased β5t expression (Supplementary 
Fig. 13) and, consequently, a loss in regular thymocyte differentiation at consecutive stages 
along the CD8SP lineage.
cTEC of Foxn1wt*/- mice had practically lost their CD83 expression (Fig. 6a). This resulted 
in 4-fold fewer CD4SP thymocytes relative to wild type animals, a decline that was 
significantly bigger than that observed in CD83 deficient (Cd83-/-) mice (Fig. 6b). Positive 
selection of DP thymoyctes, as assessed by CD69 and TCR expression, was also 
significantly lower in Foxn1wt*/- mice compared to Cd83-/- animals (Fig. 6c), suggesting 
Foxn1-dependent mechanisms other than CD83 expression to be required for positive 
selection. The acquisition of CCR7 by and the subsequent downregulation of CD24 
expression on thymocytes mark distinct stages during CD4SP lineage differentiation. Both 
were reduced in Foxn1wt*/- mice compared to wild type animals revealing a more prominent 
albeit still partial block in post-selection maturation of CD4SP Foxn1wt*/- mice compared to 
Cd83-/- animals (Fig. 6d).
Discussion
Drawing on newly created mouse models, we identified in postnatal TEC a core set of 450 
high confidence Foxn1 target genes that, among other functions, control multiple 
mechanisms essential for self-antigen processing and presentation. Our findings demonstrate 
that Foxn1 controls essential functions in TEC biology in addition to those previously noted 
to be important for initial stages in thymus organogenesis and early thymopoiesis2.
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Our in vivo ChIP-seq data using nuclear lysates from primary TEC of Foxn1wt*/wt* mice 
established the Foxn1 consensus binding motif, 5’- a/g/t-G-A-C-G-C, with a core identical 
to that previously identified by in vitro studies16,35. Although our analysis predicted 
GAAGC as an alternative motif, mutational analyses of the Psmb11 and CD83 promoters 
showed no significant functional contributions of Foxn1 binding to these sequences. 
However, productive Foxn1 binding to this alternative motif may occur in other cellular or 
developmental contexts and could depend on co-factors to specify tissue-contextual gene 
expression profiles as suggested for other Fox family members32,33. Although specific co-
factors that physically or functionally associate with Foxn1 have so far not been identified, 
our ChIP-seq data recognized several transcription factor binding motifs enriched in the 
vicinity of canonical Foxn1 binding sites, for example those for the transcriptional regulator 
TP63. An association of Foxn1 with TP63 is intriguing because TP63 maintains TEC 
stemness34, is positioned upstream of and physically interacts with the PRC1 (polycomb 
repressive complex) component CBX4, which we identified here as a high confidence Foxn1 
target. Interestingly, the lack of Cbx4 expression impairs TEC generation, proliferation and 
thymopoietic function35. In this context, it is also noteworthy that Tbata, which also 
controls TEC proliferation36, is another Foxn1 target gene we have identified.
Differences in gene expression profiles between TEC isolated from Foxn1nu/nu and wild type 
mice have previously and by inference been understood to be transcriptionally controlled by 
Foxn1, including MHCII9, Pax19 and FGFR237. However, our data exclude these loci as 
direct Foxn1 targets (at least in postnatal TEC) and suggest that their transcriptional changes 
are the indirect consequences of alterations in Foxn1 complementation. In contrast, our 
experimental approach combining ChIP-seq and gene expression profiling confirmed the 
previously suspected targets Dll4, Cxcl12 and Ccl25 to be indeed controlled by Foxn1. 
These findings provide a validated molecular explanation for the failure of Foxn1-deficient 
TEC to attract ETP38 and to assure their subsequent commitment to a T cell fate18.
Importantly, our approach also identified thymic Foxn1 target genes that function at stages 
beyond the early arrest in thymus organogenesis characteristic for Foxn1nu/nu mice and 
marked by a lack of regular homing of ETP and their commitment to the T cell lineage. 
Many of these hitherto unrecognized Foxn1 target genes are involved in thymocyte 
development and selection, with functions extending from self-antigen processing to T cell 
activation and post-selection maturation. Investigating the function of Psmb11- and Cd83-
deficient TEC, respectively, revealed the most likely molecular cause of some of the major 
phenotypic features observed in Foxn1wt*/wt* and Foxn1wt*/- mice. However, determining 
the extent of Cd83’s and Psmb11’s contributions to the observed phenotypes will necessitate 
transgenic reconstitution experiments in Foxn1-/- mice similar to those that established a 
critical role of the direct Foxn1 targets Dll4 and Cxcl12 in early T cell development41. 
Interestingly, transgenic expression of Dll4 and Cxcl12 in Foxn1-/- TEC was only sufficient 
to support thymocyte development up to the DP stage38.
The iFoxn1Δ7,8 mouse model demonstrated also the need for continuous Foxn1 expression 
to maintain regular thymopoietic activity by cTEC. Dox treatment of these mice deleted 
exons encoding the forkhead and the transcriptional activation domains and resulted in a 2-
fold reduction of full length Foxn1 transcripts within 24 hours and, a decreased expression 
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of hundreds of cTEC genes within 72 hours (≥ 3-fold: 406 genes; ≥ 2-fold: 1192 genes), 
affecting total thymocyte cellularity and early thymocyte differentiation at that point in time. 
Though at variance with a previous observation for reasons yet to be elucidated39, our 
results clearly demonstrate the importance of continued Foxn1 expression for the functional 
competence of post-natal cTEC.
Taken together, our results demonstrate for the first time that Foxn1 directly binds to and 
controls the transcription of several hundred genes that, in aggregate, control essential 
checkpoints during intrathymic T cell development. These genes are critical for the steady-
state function of adult TEC and their expression needs to be preserved for the continued 
thymopoietic competence of the thymus.
Online Methods
Mice
C57BL/6 and Foxn1nu/nu mice were obtained from Janvier and Taconic respectively. The 
generation of β5t-rtTA, and TetO-Cre animals has previously been reported11,40. Mice 
transgenic for a BAC encoding a Foxn1-Flag fusion protein under the regulatory control of 
the Foxn1 locus were generated similarly to the previously reported Foxn1-Cre mice11. 
Foxn1-Flag transgenic mice were subsequently backcrossed onto a Foxn1nu/nu background 
to obtain mice homozygous or heterozygous for the BAC transgene, designated Foxn1wt*/wt* 
and Foxn1wt*/-, respectively. Mice with a conditional Foxn1 locus where exons 7 and 8 are 
flanked by loxP sites were generated by homologous recombination, and subsequently 
crossed to β5t-rtTA and TetO-Cre transgenic animals to obtain triple transgenic mice, 
designated iFoxn1Δ7,8. Sex-matched male and female mice aged 4-7 weeks were used. No 
specific exclusion criteria were used in mouse experiments. All animals were kept under 
specific pathogen-free conditions and experiments were carried out in accordance with local 
and national regulations and permissions approved by Kantonales Veterinäramt BS.
Doxycycline Treatment
One week old iFoxn1Δ7,8 mice were treated with a single intraperitoneal (i.p.) injection of 
Dox (0.3mg).
Flow Cytometry
Thymocytes were incubated with Abs against TCR beta (1:400, H57-597; Biolegend), CD4 
(1:1000, GK1.5; BioLegend), CD5 (1:400, 53-7.3, eBioscience), CD8 (1:500, 53-67; 
BioLegend), CD25 (1:1000, PC61.5; BioLegend), CD44 (1:500, IM7; BioLegend), c-kit 
(1:200, 2B8; BioLegend), CD24 (1:1000, M1/69; BioLegend), CD69 (1:200, H1.2F3; 
BioLegend), PD-1 (1:200, 29F.1A12, Biolegend), CCR7 (1:200, 4B12, BioLegend). For 
intracellular staining, cells were fixed, permeabilized (Fixation/Permeabilization kit, 
eBioscience) and stained for Foxp3 (1:70, FJK-16S, eBioscience) and Helios (1:70, 22F6, 
eBioscience). TECs were stained using Abs against CD45 (1:400, 30F11; BioLegend), 
EpCAM (1:1000, G8.8; BioLegend), MHCII (1:1000, M5/114.15.2; BioLegend), Ly51 
(1:1000, 6C3; BioLegend), UEA-1 (1:1000, Reactolab), CD80 (1:500, 16-10A1, Biolegend), 
CD86 (1:500, GL-1, Biolegend), CD83 (1:500, Michel 19, Biolegend). For intracellular 
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staining, cells were fixed, permeabilized (Cytofix/Cytoperm Kit, BD Biosciences) and 
labelled for the expression of CD83. Stained samples were acquired on a FACSAria II or BD 
LSRFortessa flow cytometers and the data was analyzed using the FlowJo (Treestar) 
software.
Quantitative PCR analysis
Total RNA was isolated from sorted cells with the RNeasy Kit (Qiagen), cDNA was 
synthesized using SuperScriptIII (Live Technologies) and assessed by qPCR (SensiMix; 
Bioline).
ChIP-seq—Thymic lobes from one week old Foxn1wt*/wt* mice were digested with 
0.2mg/ml Liberase TM (Roche Diagnostics) and 30µg/ml DNaseI (Roche Diagnostics) in 
PBS at 37°C for 30-60 min. TECs were enriched to 15-20% using magnetic beads 
(autoMACS Pro Separator, Miltenyi Biotech) and then subjected to DNA crosslinking. 
Nuclear isolation and chromatin fragmentation were performed with 20-30 x 106 cells 
enriched for TEC using the truChIP High Cell Chromatin Shearing Kit with nonionic 
Shearing Buffer according to the manufacturer’s recommendations (Covaris). Chromatin 
was immunoprecipitated using the M2 anti-FLAG antibody (F1804; Sigma) with parallel 
input samples prepared from non-immunoprecipitated chromatin41. To increase the 
specificity of ChIP-seq analysis, it would have been ideal to include immunoprecipitated 
chromatin from wild type TEC as negative control but the large amount of material required 
made this approach infeasible. Precipitated DNA from TEC-enriched (15-20%) and control 
thymocyte only samples was subjected to qPCR analysis using primers specific to promoter 
regions of Psmb11 and Dll4 (both TEC specific genes) and Foxp3 (thymocyte specific gene) 
(Supplementary Fig. 3a). DNA samples from multiple ChIP showing successful enrichment 
of TEC candidate gene promoters were pooled to generate two replicates (5ng each) for 
library generation and sequencing. Contaminating adapter sequences were removed from 
fastq sequences using Trimmomatic (version 0.32). Reads were aligned against the mouse 
genome (UCSC build mm10) using pre-alignment with BWA (version 0.7.5 with the options 
-q10 -t4) and final alignment was achieved with Stampy (version 1.0.23 with the options -t4 
--bamkeepgoodreads - M)42,43. Peaks were called on deduplicated aligned sequences 
(paired ChIP and input samples) using MACS2 (version 2.0.10) with a relaxed p-value 
setting of 0.144. Peaks from replicates were then pooled and analysed using irreproducible 
discovery rate analysis (IDR < 0.05) (https://sites.google.com/site/anshulkundaje/projects/
idr). Peaks were filtered against the ENCODE blacklist regions (https://sites.google.com/
site/anshulkundaje/projects/blacklists).
RNA-seq—TECs were enriched as detailed above and then sorted using a FACSAria II 
(BD Bioscience). RNA was isolated using RNeasy kit (Qiagen) and subjected to sequencing 
(TrueSeq, BGI). Reads were aligned against the Ensembl transcriptome and genome 
(GRCm38) using Tophat2 (version 2.0.10). Reads were allocated to protein-coding gene 
meta-features using Rsubread (requiring both pairs of reads to be aligned and excluding 
multimapping reads). Exon-level expression data was estimated using BEDtools coverage. 
Differential expression analysis on genes with at least 1 aligned fragment was conducted 
using general linear modelling in edgeR, correcting for common, trended and tagwise 
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dispersion, with additional batch correction for the conditional Foxn1 knock-out model45. 
Genes were identified as differentially expressed using the default edgeR threshold (FDR < 
0.05).
ATAC-seq—A cell pellet of ~10,000 cTEC was lysed, treated with transposase and DNA 
tagmented in accordance with a previously published protocol46. Tagmented fragments were 
amplified by PCR and sequenced using an Illumina MiSeq on 75bp paired end reads. 
Trimmomatic was used to trim Kmer biases from reads (version 0.32). Fragments were 
aligned to the mm10 genome using Bowtie2 (version 2.2.3 with the options --no-discordant 
--no-mixed -X 2000). Read positions were corrected for transposon insertion offset. The 
significance of differences in coverage between sets of genes was estimated using Wilcoxon 
rank sum tests. ATAC-seq peaks were called using MACS2 (with the options --nomodel --
nolambda --keep-dup all --call-summits; FDR < 0.05). Peaks were screened against 
blacklisted regions.
Statistical analysis of ChIP-seq and RNA-seq—De novo motif discovery within 
Foxn1 ChIP-seq peaks was carried out using MEMEChIP on the 200 base-pairs surrounding 
the peak summit. Background nucleotide content was controlled for using a first-order 
Markov model. Motif location was identified using FIMO with a threshold of p < 0.05 on 
repeat-masked fasta files using a first-order Markov background. The sequence within 100 
bases of each ChIP-seq summit was classified as either containing or not containing a 
version of each candidate Foxn1 recognition motif. General linear regression, adjusting for 
GC content within 100 bases of each ChIP-seq summit, was performed to test the predictive 
power of each motif’s presence for the significance score assigned to each summit by 
MACS2. Central enrichment was tested by permuting the position of motifs within 1kb of 
peak summit 10,000 times and assessing the number of motifs falling into a 200 base central 
window. Foxn1 ChIP-seq peaks were scanned for co-factor motifs using PScanChIP and a 
mixed background24. Genomic enrichment was calculated using GAT with 10,000 
randomisations, controlling for GC content and using an appropriate workspace as 
background. Genomic features were annotated using HOMER. ChIP-seq peaks were 
allocated to genes using a window of 5kb upstream and 100 bases downstream of the TSS. 
This gene definition was selected to be comparable to ChIP-seq annotation methods such as 
GREAT but using greater stringency. To establish whether Foxn1 functioned predominantly 
as a repressor or activator of transcription, we used BETA to integrate the Foxn1 ChIP-seq 
peaks and cTEC RNA-seq datasets from iFoxn1Δ7,8 mice (using default settings)19. We then 
restricted Foxn1 direct gene targets to those significantly differentially expression in the 
appropriate direction as a result of Foxn1 deficiency and with a Foxn1 binding site within 
5kb upstream or 100 bases downstream of the TSS.
Co-expression analysis—Microarray expression data was downloaded from 
GSE5692823. This was quantile normalised and a thymic epithelial cell-specific (cTEC, 
mTEClo and mTEChi) signed co-expression network constructed using bidirectional 
weighted correlation in WGCNA22. The optimal soft threshold power was chosen to achieve 
r2 > 0.9 for the network. Individual sets of genes were analysed by permutation analysis, 
controlling for expression deciles. This dataset was also used to generate a list of genes 
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likely to be primarily driven by non-TEC contaminating thymic stromal cells. To this end, 
the dataset was screened for genes displaying significant differences on ANOVA testing 
between TECs and non-TECs, 4-fold higher expression in non-TECs than TECs and an 
expression level in TECs within the bottom quintile of genes.
Gene ontology analysis—Gene ontology analysis was conducted using DAVID20. All 
enriched GO terms with Benjamini-Hochberg corrected p-values < 0.05 and > 2-fold 
enrichment were shown in the relevant figures.
Histological analyses
Frozen thymus tissue sections (8µm) were fixed in acetone and stained using Abs specific 
for Psmb11 (1:500, PD021, MBL), CD4 (1:200, GK1.5; BioLegend), CK5 (1:500, 
PRB-160P, Covance), CK8 (1:200, TROMA-1, NICHD supported Hybridoma Bank), 
ERTR7 (1:50, provided by W. van Ewijk, Netherlands), Foxn1 (1:1000, provided by T. 
Amagai, Japan) and Aire (1:200, 5H12, eBioscience). Images were acquired using a Zeiss 
LSM510 (Carl Zeiss).
Luciferase assay
Promoter fragments of Psmb11 and Cd83 were subcloned into the pGL4.10(luc2, Promega) 
reporter plasmid and co-transfected with an expression vector encoding Foxn1 into HEK293 
cells using FuGENE HD (Promega). Luciferease activity was measured 24hr later using the 
Dual-Lucifearase Assay kit (Promega). Motifs were mutated using Q5 Site-Directed 
Mutagenesis Kit (NEB).
Statistical analyses
Statistical analyses for data presented were performed using Students t test (unpaired, two-
tailed). P < 0.05 was considered significant. The statistical evaluation of the ChIP-seq and 
RNA-seq data is described in separate statistical analysis section above. The sample size 
used and estimates of variation within groups were based on published results using similar 
approaches. No randomization was done for animal studies and investigators were not 
blinded to experimental group allocations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Transgenic rescue of nude phenotype in Foxn1wt*/wt* mice expressing a chimeric Foxn1-
Flag protein. (a) Absolute thymus cellularity of mice with indicated genotype and age. (b, c) 
Immunofluorescence analysis of thymus tissue from 4 week old mice with indicated 
genotype (b) for the expression of cytokeratin 8 (CK8; a cortical TEC marker, blue), CK5 (a 
medullary TEC marker, green), and ERTR7 (endothelial cells and fibroblasts; red), and (c) 
for the expression of Foxn1 (red) and the Autoimmune Regulator (Aire, identifying a 
subpopulation of mature mTEC; blue). Scale bar 50µm (c) and 100µm (b). (d) RT-qPCR 
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analysis of functional Foxn1 transcripts in cTEC from Foxn1wt*/wt* and Foxn1wt*/- mice 
using oligonucleotides specific for transgene specific FLAG tag sequence. Values are 
normalized to EpCAM expression. (e) Flow cytometric analysis of TEC subpopulations 
isolated from 4 week old mice with the indicated genotype (left panels). The gating strategy 
is detailed in Supplementary Fig. 1e. Frequencies of cTEC and mTEC in middle and right 
panels, respectively. (f,g) Flow cytometric analysis of mTEC isolated from 4 week old mice 
mice with the indicated genotype for the expression of MHCII and (f) CD80 or (g) CD86. 
Frequencies of double positive cells displayed on the right. (h) Flow cytometric analysis of 
MHCII expression on cTEC and mTEC isolated from 4 week old mice with the indicated 
genotypes. Bar graph displays frequencies of MHCIIhi cells as defined by the gate in the 
histograms. *p<0.05. (Student’s t-test (a,d-h)). Data in bar graphs are pooled from two 
(a,e,h) independent experiments (n=7, mean ±SD ) or display one experiment (b,c,f,g) 
representative of two independent experiments with four replicates each. Contour plots (e-g) 
and histograms (h) are representative of data in bar graphs. Numbers shown in individual 
gates and quadrants of flow cytometry plots represent the frequencies observed in a 
representative experiment. ND: not detected
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Figure 2. 
Foxn1 availability in TEC determines T cell developmental defects. Flow cytometric 
analysis of 4 week old mice with indicated genotype for (a) CD44+c-kit+ thymocytes. Bar 
graph display frequencies of CD44+c-kit+CD25- thymocytes. (b) CD44 and CD25 
expression on CD4-CD8-Lin- thymocytes, (c) CD4 and CD8 expression on total thymocytes; 
(d) CD69 and TCR β-chain expression on total thymocytes; (e) Helios and PD1 expression 
on Foxp3-CCR7- thymocytes; (f) CD24 and CCR7 expression on 
CD4+CD8-TCR+CD5+Foxp3- thymocytes; (g) CD24 and CCR7 expression on 
Žuklys et al. Page 18
Nat Immunol. Author manuscript; available in PMC 2017 February 22.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
CD4-CD8+TCR+CD5+ thymocytes; and (h) Foxp3 and CD25 expression by 
CD4+CD8-TCR+CD5+ thymocytes. Representative contour plots for (h) are displayed in 
Supplementary Fig. 2c. *p<0.05. (Student’s t-test (a-h). Data in bar graphs are from one 
experiment representative of two independent experiments with four replicates each. 
Contour plots (a-g) are representative of data in bar graphs. Numbers shown in individual 
gates and quadrants of flow cytometry plots represent the frequencies observed in a 
representative experiment.
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Figure 3. 
Foxn1 ChIP-seq analysis. (a) Proportion of Foxn1 ChIP-seq peaks falling within different 
RefSeq meta-gene regions. (b) Left: Enrichment of Foxn1 ChIP-seq signal across a meta-
gene profile comprising all RefSeq mouse genes relative to control. TSS = transcriptional 
start site; TES = transcriptional end site. Right: Relative coverage of cTEC ATAC-seq 
transposon insertions relative to the summit of Foxn1 ChIP-seq peaks. (c) MEMEChIP-
derived Foxn1 binding site motif for TSS-associated peaks (-5kb before and 100bp after 
TSS, E-value < 10-80). (d) Motif coverage relative to the summit of Foxn1 ChIP-seq peaks 
for TSS-associated peaks.
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Figure 4. 
Intersection of Foxn1 ChIP-seq and RNA-seq analyses. (a) Thymus cellularity and 
expression of c-kit and CD25 on CD4-CD8-Lin- thymocytes in one week old iFoxn1Δ7,8 
mice 72hrs after i.p. exposure to Doxycycline (Dox+) or saline (Dox-). (b) Left: Foxn1 
ChIP-seq binding profiles for Ccl25, Cxcl12 and Dll4. Scale bars represent 5kb (top) and 
2kb (middle and bottom). Right: RT-qPCR analysis for Cxcl12, Dll4, Ccl25 and Foxn1 
transcripts in cTECs isolated at the indicated times after treatment of one week old 
iFoxn1∆7,8 mice with a single dose of Dox relative to untreated iFoxn1∆7,8 mice. (c) Number 
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of with decreased Foxn1 activity downregulated genes filtered from all protein coding 
Ensembl genes by sequential use of indicated data sets. ChIP-seq targets were defined as 
genes with a Foxn1 peak (IDR < 0.05) 5kb upstream or 100 bases downstream of the TSS. 
Genes with FDR < 0.05 were called as differentially expressed. (d) Distribution of Foxn1 
ChIP-seq peaks around the transcriptional start site (TSS) of genes categorized by the 
direction of change in TetO-iFoxn1∆7,8 vs TetO+iFoxn1∆7,8 mice following Dox treatment. 
(e) ATAC-seq signal in cTEC near the TSS of high confidence Foxn1 target genes (red) and 
all other genes (gray; 1.54-median fold change). (f) Scatter plot analysis of expression levels 
of high confidence Foxn1 targets (red: >2-fold; blue: <2-fold differential expression). (g) 
Gene ontology analysis of high confidence Foxn1 gene targets. The number of high 
confidence targets in each term (> 2 fold enrichment) are: threonine peptidase 8 
(representing 38.1% of genes in that gene ontology category); proteasome 9 (16.7%); transit 
peptides 23 (5.0%); protein trafficking 23 (5.0%) and Golgi apparatus 26 (4.7%). *p<0.05. 
(Student’s t-test (a,b); Benjamini-Hochberg (g)).
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Figure 5. 
Psmb11 and Cd83 are direct targets of Foxn1. (a) Left: Foxn1 ChIP-seq binding profiles for 
Psmb11 and Cd83. Scale bars 2kb (top) and 5kb (bottom). Right: RT-qPCR analysis of gene 
expression in cTEC isolated from one week old iFoxn1∆7,8 mice at the indicated times after 
treatment with a single dose of Dox relative to untreated iFoxn1∆7,8 mice. Measurements of 
transcripts of the rtTA transgene replacing the endogenous Psmb11 locus in homozygous 
iFoxn1∆7,8 mice. (b,c) Luciferase assays for the Foxn1-dependent activation of wild type 
(wt) Psmb11 and Cd83 minimal promoters and of Psmb11 and Cd83 promoter mutants 
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(mut1-4) containing alterations in the GACGC (black bars) and GAAGC motifs (black 
ovals). (d-h) Comparative analysis of the impact of a loss of Psmb11 expression and 
expression of a hypomorphic Foxn1 allele, respectively, on intrathymic T cell development 
of 5 week old mice with indicated genotype for (d) CD4 and CD8 expression on 
thymocytes, (e) CD69 and TCR β-chain expression on thymocytes, (f) Helios and PD-1 on 
Foxp3-CCR7- thymocytes, (g) CD5 and TCR β-chain expression CD4+CD8+ thymocytes, 
and (h) CD24 and CCR7 expression on CD8SP thymocytes. *p<0.05. (Student’s t-test). 
Data is representative of two independent experiments (mean ±SD) with sample sizes of four 
(d-h) and three measurements each (a-c). Contour plots (d-h) are representative of data in 
bar graphs. Numbers shown in individual gates and quadrants of flow cytometry plots 
represent the frequencies observed in a representative experiment.
Žuklys et al. Page 24
Nat Immunol. Author manuscript; available in PMC 2017 February 22.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 6. 
Comparative analysis of the impact of a loss of Cd83 expression and expression of a 
hypomorphic Foxn1 allele, respectively, on intrathymic T cell development. Analysis of 5 
(Foxn1wt*/-) and 7 (Cd83+/+, Cd83-/-) week old mice with indicated genotype for (a) 
EpCAM and CD83 expression on cTEC (CD45-EpCAM+MHCII+UEA1-Ly51+), (b) CD4 
and CD8 expression on total thymocytes, (c) CD69 and TCR β-chain expression on total 
thymocytes, (d) CD24 and CCR7 expression on CD4SP thymocytes. *p<0.05. (Student’s t-
test (a-d). Data in bar graphs is representative of two independent experiments (mean ±SD ) 
with sample sizes of three. Contour plots are representative of data in bar graphs. Numbers 
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shown in individual gates and quadrants of flow cytometry plots represent the frequencies 
observed in a representative experiment.
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Table 1
Top 30 Foxn1 target genes.
Gene symbol Foxn1wt*/- vs. Foxn1wt*/wt* cTEC TetO+ vs. TetO- iFoxn1Δ7,8 cTEC
Log2 fold change FDR Log2 fold change FDR
Ccl25 7.43 0 3.99 3.4E-35
Prss16 4.77 2.1E-121 3.27 5.88E-31
Gpr25 4.33 4.53E-57 2.59 3.57E-16
Tspan10 4.30 6.76E-10 2.44 2.04E-09
AA467197 4.12 4.01E-38 2.55 3.51E-16
Cd83 3.99 5.9E-191 2.75 4.42E-28
Tbata 3.70 1.6E-189 3.88 4.65E-31
Ajap1 3.29 1.34E-67 2.35 1.5E-24
5031414D18Rik 3.27 1.84E-41 2.47 1.97E-16
Psmb11 3.25 2.4E-280 1.67 0.005563
Apba2 3.20 2.5E-199 1.09 1.25E-12
Dtx4 3.09 4.54E-95 1.31 1.34E-12
Pds5b 3.08 1.5E-191 1.12 1.29E-10
Stc2 3.06 4.48E-35 1.55 1.35E-06
Zar1 2.98 1.41E-10 2.46 2.8E-08
Snap91 2.98 1E-121 2.36 2.55E-30
Srxn1 2.93 0 1.12 9.63E-11
Ctnna2 2.89 2.85E-24 1.78 3.76E-05
Lhx3 2.78 0.0212 2.34 0.033605
Cecr6 2.73 4.9E-132 2.93 5.55E-20
Ankmy1 2.70 1.66E-19 2.43 9.39E-10
Tmie 2.68 1.85E-70 1.15 3.47E-11
Abca15 2.67 0.00155 2.38 0.005563
Gmfg 2.67 7.93E-12 0.74 0.018435
Arhgef10l 2.66 0 1.33 9.78E-17
Ptprn2 2.60 2.17E-48 2.01 1.72E-12
Lmx1a 2.59 1.18E-11 2.79 7.24E-06
Endou 2.55 6.52E-14 0.86 0.001829
Mfsd12 2.45 5.7E-217 2.10 2.2E-25
Akap2 2.29 1.27E-25 0.82 0.014184
Top 30 high confidence Foxn1 regulated genes ranked by log2 fold change. High confidence genes (FDR<0.05) are those with a Foxn1 ChIP-seq 
peak 5kb upstream or 100 bases downstream of the transcription start site, and down-regulated in cTEC of Foxn1wt*/- mice relative to cTEC of 
Foxn1wt*/wt* mice and cTEC from Dox treated iFoxn1Δ7,8 mice mice relative to Dox treated iFoxn1Δ7,8 mice lacking the TetO-Cre transgene. 
Positive fold change indicates higher expression in Foxn1wt*/- mice compared to Foxn1wt*/wt* mice or Dox treated iFoxn1Δ7,8 mice mice 
relative to Dox treated iFoxn1Δ7,8 mice lacking the TetO-Cre transgene.
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